SCHEMBL7984470

SCHEMBL7984470

CCc1nc(=O)c2c(ncn2Cc2ccc(C(C)(C)C)cc2)[nH]1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ABCC8 Q09428 1/20 0.50
KCNJ11 Q14654 1/20 0.50
CNOT7 Q9UIV1 3/20 0.40
PARN O95453 1/20 0.40
NR1H4 Q96RI1 5/20 0.37
CYP11B1 P15538 1/20 0.36
CYP11B2 P19099 1/20 0.36
LMNA P02545 1/20 0.36
MAPK1 P28482 1/20 0.36
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36
NR1I2 O75469 1/20 0.35
ADORA2B P29275 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34
METAP2 P50579 1/20 0.34
HPGD P15428 1/20 0.34
POLB P06746 1/20 0.34
TDP1 Q9NUW8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7984748 0.91 ABCC8 (0.48) ABCC8KCNJ11CNOT7PARNNR1H4
SCHEMBL7991686 0.89 ABCC8 (0.48) ABCC8KCNJ11CNOT7PARNNR1H4
Hydrochloric Acid SCHEMBL7985467 0.88 ABCC8 (0.47) ABCC8KCNJ11CNOT7PARNNR1H4
SCHEMBL7985645 0.88 ABCC8 (0.47) ABCC8KCNJ11CNOT7PARNNR1H4
SCHEMBL7987439 0.87 CNOT7 (0.43) CNOT7PARNCYP11B1CYP11B2LMNA
SCHEMBL7984530 0.86 HPGD (0.46) CNOT7PARNCYP11B2KMT2AMEN1
SCHEMBL7988132 0.86 CNOT7 (0.44) CNOT7PARNLMNAMAPK1SMN1; SMN2
SCHEMBL7975254 0.85 CNOT7 (0.55) CNOT7PARNKMT2AADORA2BSMN1; SMN2
SCHEMBL7973938 0.84 CNOT7 (0.48) CNOT7PARNCYP11B1CYP11B2KMT2A
SCHEMBL8059826 0.83 YTHDC1 (0.45) CNOT7PARNNR1H4KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed